87
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Effects of Topical Travoprost and Unoprostone on Optic Nerve Head Circulation in Normal Rabbits

, , &
Pages 743-749 | Received 28 Feb 2007, Accepted 20 Jun 2007, Published online: 02 Jul 2009

REFERENCES

  • Thylefors B, Negrel A D, Pararajasegaram R, Dadzie K Y. Global data on blindness. Bull World Health Organ. 1995; 73(1)115–121
  • Foster A, Johnson G. Blindness in the developing world. Br J Ophthalmol. 1993; 77(7)398–399
  • Quigley H A. Number of people with glaucoma worldwide. Br J Ophthalmol. 1996; 80(5)389–393
  • Iwase A, Suzuki Y, Araie M, et al. The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study. Ophthalmology. 2004; 111(9)1641–1648
  • Quigley H A, Broman A T. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006; 90(3)262–267
  • Bonomi L, Marchini G, Marraffa M, et al. Vascular risk factors for primary open angle glaucoma: the Egna-Neumarkt Study. Ophthalmology. 2000; 107(7)1287–1293
  • Cioffi G A, Sullivan P. The effect of chronic ischemia on the primate optic nerve. Eur J Ophthalmol 1999; 9: S34–S36, (Suppl 1)
  • Fuchsjager-Mayrl G, Wally B, Georgopoulos M, et al. Ocular blood flow and systemic blood pressure in patients with primary open-angle glaucoma and ocular hypertension. Invest Ophthalmol Vis Sci. 2004; 45(3)834–839
  • Hayreh S S, Zimmerman M B, Podhajsky P, Alward W L. Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol 1994; 117(5)603–624
  • Satilmis M, Orgul S, Doubler B, Flammer J. Rate of progression of glaucoma correlates with retrobulbar circulation and intraocular pressure. Am J Ophthalmol 2003; 135(5)664–669
  • Kondo Y, Niwa Y, Yamamoto T, et al. Retrobulbar hemodynamics in normal-tension glaucoma with asymmetric visual field change and asymmetric ocular perfusion pressure. Am J Ophthalmol 2000; 130(4)454–460
  • Ishii K, Tomidokoro A, Nagahara M, et al. Effects of topical latanoprost on optic nerve head circulation in rabbits, monkeys, and humans. Invest Ophthalmol Vis Sci 2001; 42(12)2957–2963
  • Sponsel W E, Mensah J, Kiel J W, et al. Effects of latanoprost and timolol-XE on hydrodynamics in the normal eye. Am J Ophthalmol 2000; 130(2)151–159
  • Geyer O, Man O, Weintraub M, Silver D M. Acute effect of latanoprost on pulsatile ocular blood flow in normal eyes. Am J Ophthalmol 2001; 131(2)198–202
  • Tamaki Y, Nagahara M, Araie M, et al. Topical latanoprost and optic nerve head and retinal circulation in humans. J Ocul Pharmacol Ther. 2001; 17(5)403–411
  • Poinoosawmy D, Indar A, Bunce C, et al. Effect of treatment by medicine or surgery on intraocular pressure and pulsatile ocular blood flow in normal-pressure glaucoma. Graefes Arch Clin Exp Ophthalmol. 2002; 240(9)721–726
  • Sponsel W E, Paris G, Trigo Y, Pena M. Comparative effects of latanoprost (Xalatan) and unoprostone (Rescula) in patients with open-angle glaucoma and suspected glaucoma. Am J Ophthalmol. 2002; 134(4)552–9
  • McKibbin M, Menage M J. The effect of once-daily latanoprost on intraocular pressure and pulsatile ocular blood flow in normal tension glaucoma. Eye 1999; 13: 31–34, (Pt 1)
  • Sharif N A, Davis T L, Williams G W. [3H]AL-5848 ([3H]9beta-(+)-Fluprostenol). Carboxylic acid of travoprost (AL-6221), a novel FP prostaglandin to study the pharmacology and autoradiographic localization of the FP receptor. J Pharm Pharmacol 1999; 51(6)685–694
  • Hellberg M R, Sallee V L, McLaughlin M A, et al. Preclinical efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist. J Ocul Pharmacol Ther 2001; 17(5)421–432
  • Parrish R K, Palmberg P, Sheu W P. A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study. Am J Ophthalmol 2003; 135(5)688–703
  • Przydryga J T, Egloff C. Intraocular pressure lowering efficacy of travoprost. Eur J Ophthalmol 2004; 14(5)416–422
  • Sharif N A, Kelly C R, Crider J Y. Agonist activity of bimatoprost, travoprost, latanoprost, unoprostone isopropyl ester and other prostaglandin analogs at the cloned human ciliary body FP prostaglandin receptor. J Ocul Pharmacol Ther 2002; 18(4)313–324
  • Ota T, Aihara M, Narumiya S, Araie M. The effects of prostaglandin analogues on IOP in prostanoid FP-receptor-deficient mice. Invest Ophthalmol Vis Sci 2005; 46(11)4159–4163
  • Inan U U, Ermis S S, Orman A, et al. The comparative cardiovascular, pulmonary, ocular blood flow, and ocular hypotensive effects of topical travoprost, bimatoprost, brimonidine, and betaxolol. J Ocul Pharmacol Ther 2004; 20(4)293–310
  • Makimoto Y, Sugiyama T, Kojima S, Azuma I. Long-term effect of topically applied isopropyl unoprostone on microcirculation in the human ocular fundus. Jpn J Ophthalmol 2002; 46(1)31–35
  • Tamaki Y, Araie M, Tomita K, et al. Effect of topical unoprostone on circulation of human optic nerve head and retina. J Ocul Pharmacol Ther 2001; 17(6)517–527
  • Briers J D, Fercher A F. Retinal blood-flow visualization by means of laser speckle photography. Invest Ophthalmol Vis Sci 1982; 22(2)255–259
  • Tamaki Y, Araie M, Kawamoto E, et al. Non-contact, two-dimensional measurement of tissue circulation in choroid and optic nerve head using laser speckle phenomenon. Exp Eye Res 1995; 60(4)373–383
  • Tomita K, Araie M, Tamaki Y, et al. Effects of nilvadipine, a calcium antagonist, on rabbit ocular circulation and optic nerve head circulation in NTG subjects. Invest Ophthalmol Vis Sci 1999; 40(6)1144–1151
  • Takayama J, Tomidokoro A, Ishii K, et al. Time course of the change in optic nerve head circulation after an acute increase in intraocular pressure. Invest Ophthalmol Vis Sci 2003; 44(9)3977–3985
  • Takayama J, Tomidokoro A, Tamaki Y, Araie M. Time course of changes in optic nerve head circulation after acute reduction in intraocular pressure. Invest Ophthalmol Vis Sci 2005; 46(4)1409–1419
  • Tamaki Y, Araie M, Tomita K, Tomidokoro A. Time change of nicardipine effect on choroidal circulation in rabbit eyes. Curr Eye Res 1996; 15(5)543–548
  • Tamaki Y, Araie M, Kawamoto E, et al. Noncontact, two-dimensional measurement of retinal microcirculation using laser speckle phenomenon. Invest Ophthalmol Vis Sci 1994; 35(11)3825–3834
  • Tomidokoro A, Araie M, Tamaki Y, Tomita K. In vivo measurement of iridial circulation using laser speckle phenomenon. Invest Ophthalmol Vis Sci 1998; 39(2)364–371
  • Sugiyama T, Utsumi T, Azuma I, Fujii H. Measurement of optic nerve head circulation: comparison of laser speckle and hydrogen clearance methods. Jpn J Ophthalmol 1996; 40(3)339–343
  • Ishii K, Matsuo H, Fukaya Y, et al. Iganidipine, a new water-soluble Ca2+ antagonist: ocular and periocular penetration after instillation. Invest Ophthalmol Vis Sci 2003; 44(3)1169–1177
  • Mizuno K, Koide T, Saito N, et al. Topical nipradilol: effects on optic nerve head circulation in humans and periocular distribution in monkeys. Invest Ophthalmol Vis Sci 2002; 43(10)3243–3250
  • Taniguchi T, Haque M S, Sugiyama K, et al. Ocular hypotensive mechanism of topical isopropyl unoprostone, a novel prostaglandin metabolite-related drug, in rabbits. J Ocul Pharmacol Ther 1996; 12(4)489–498
  • Sugiyama T, Azuma I. Effect of UF-021 on optic nerve head circulation in rabbits. Jpn J Ophthalmol 1995; 39(2)124–129
  • Ota T, Aihara M, Saeki T, et al. The effects of prostaglandin analogues on prostanoid EP1, EP2, and EP3 receptor-deficient mice. Invest Ophthalmol Vis Sci 2006; 47(8)3395–3399
  • Wu K Y, Wang H Z, Hong S J. Inhibition of endothelin-1 and KCL-induced increase of [CA2+]i by antiglaucoma drugs in cultured A7r5 vascular smooth-muscle cells. J Ocul Pharmacol Ther 2004; 20(3)201–209
  • Thieme H, Steinhausen K, Ottlecz A, et al. Effects of unoprostone and endothelin 1 on L-type channel currents in human trabecular meshwork cells. Ophthalmic Res 2005; 37(6)293–300
  • Yoshitomi T, Yamaji K, Ishikawa H, Ohnishi Y. Vasodilatory mechanism of unoprostone isopropyl on isolated rabbit ciliary artery. Curr Eye Res 2004; 28(3)167–174

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.